Taichung, Taiwan

Chih-Ming Pan

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Chih-Ming Pan: Innovator in Antibody and Fusion Protein Technologies

Introduction

Chih-Ming Pan is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the fields of immunology and biotechnology, holding a total of eight patents. His work focuses on developing innovative solutions for treating infections and cancer.

Latest Patents

Among his latest patents is an anti-specific antibody and the nucleic acid encoding sequence thereof, which provides a method for treating infections and enhancing immune cell activity. This invention has shown promising results through various efficacy experiments. Another notable patent is for a fusion protein and its nucleic acid encoding sequence, which aims to treat cancer, regulate immune responses, and activate immune cells, also validated through extensive testing.

Career Highlights

Chih-Ming Pan has worked with reputable institutions, including China Medical University Hospital and Shine-On Biomedical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Throughout his career, Chih-Ming Pan has collaborated with esteemed colleagues such as Der-Yang Cho and Shao-Chih Chiu. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Chih-Ming Pan's innovative work in antibody and fusion protein technologies has the potential to revolutionize treatments for infections and cancer. His contributions to the field are invaluable and continue to inspire future advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…